75A50325C00020↗

Name: 75A50325C00020: Rafa Atropine Auto-Injectors (0.5 MG, 1 MG, and 2 MG)
Creator: SpendQuery
License: https://www.usa.gov/government-works

Rafa Laboratories LTD received this contract from Aspr/Orm-Sns, Office of Assistant Secretary for Preparedness and Response: $33.39M obligated so far for drugs and biologicals. It runs to 2027-09-29, or to 2028-09-29 if every option is exercised.

Key facts · data as of Oct 23, 2026

Recipient: Rafa Laboratories LTD
Awarding agency: Office of Assistant Secretary for Preparedness and Response (Department of Health and Human Services)
Contracting office: Aspr/Orm-Sns (75A503)
Obligated to date: $33.39M
Potential value: $46.21M
Ends: 2027-09-29

Source: USAspending.gov prime award records (obligations: money committed, not outlays), data as of Oct 23, 2026.

Cite this page: SpendQuery, Award 75A50325C00020, data as of Oct 23, 2026, https://spendquery.com/award?id=CONT_AWD_75A50325C00020_7505_-NONE-_-NONE-

Rafa Laboratories LTD: all federal awards · Department of Health and Human Services: spending · Aspr/Orm-Sns: what it buys · The follow-on: recompete brief

RAFA ATROPINE AUTO-INJECTORS (0.5 MG, 1 MG, AND 2 MG)

Definitive Contract · Office of Assistant Secretary for Preparedness and Response · to Rafa Laboratories LTD (UEI CKDNTKNDPMJ6) · data as of 2026-10-23

Obligated to date$33.39M2 actions

Current value$33.39Mwith options exercised

Potential value$46.21Mif every option is used

Period2025-09-30 → 2027-09-29up to 2028-09-29 with options

Up for re-bid: ends 2027-09-29. Recompete brief →

What it is

Product or service: Drugs and Biologicals (PSC 6505)
Industry: Pharmaceutical Preparation Manufacturing (NAICS 325412)
Contracting office: Aspr/Orm-Sns (75A503)
Competition: Not competed · 1 offer received
Pricing: Firm fixed price
How it was bought: Standalone contract
Where the work is: ISR

Obligations by fiscal year

FY2025$20.95M

FY2026$12.45M

SpendQuery holds FY2023 on; earlier years are on USAspending.gov.

Subcontractors: where the money went next

No subawards reported for this award. Primes report subawards of $30,000 or more; many awards have none.

Every action

2 actions since 2025-09-30. Each is a modification or amendment with the money it added or took back.

Date	Modification	Kind	Amount	What the agency wrote
2026-07-29	P00001	Option exercised	$12.45M	EXERCISE OPTION FOR ATROPINE AUTO-INJECTORS (0.5 MG, 1 MG, AND 2 MG)
2025-09-30	0		$20.95M	RAFA ATROPINE AUTO-INJECTORS (0.5 MG, 1 MG, AND 2 MG)

Source: USAspending.gov prime award transactions and FSRS subaward reports, as loaded by SpendQuery (data as of 2026-10-23). Amounts are obligations (money committed), not outlays. The official record on USAspending.gov ↗

Putting the award page together from the records…